Autoinjectors Market Analysis
Autoinjectors market by Product Type (Disposable and Reusable), Autoinjectors market by Type (Prefilled and Fillable), Autoinjectors market by Portability (Handheld and Wearable), Autoinjectors market by Indication (Rheumatoid Arthritis, Diabetes, Anaphylaxis, Multiple Sclerosis, And Others), Autoinjectors market by End User (Hospitals, Clinics, and Homecare Settings), and Autoinjectors market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the product segment of the autoinjectors market insights, the disposable autoinjectors category was estimated to amass a larger market share in the historic period. This can be attributed to their preferred use among end-users due to the presence of a built-in glass syringe which eliminated the need for the manual insertion of the glass syringe. These types of syringes prove to be really useful for patients with visual impairments and reduced limb mobility.
However, owing to the technological advancements in product development, there has been increase in the number of reusable autoinjectors in the market. These autoinjectors allow for the replacement of the drug cartridges after the expiration of the shelf-life. Moreover, to keep up with the demand for smart technologies in the market, companies have also started offering smart reusable autoinjectors as well such as SmartPilot and Aria Smart Autoinjector, thereby projecting a fast growth period for this product category in the forecast period.
What are the Autoinjectors Companies?
Some of the key market players operating in the autoinjectors market includes BD, Ysmoed AG, Sonceboz, Phillips-Medisize, Nemera, Novartis, Teva Pharmaceuticals, Amgen, GSK, Mylan Inc, Elcam Medical, Union Medico Injection Safety ApS, SHL Medical AG, Haselmeier, Owen Mumford Ltd, and others.
